PDCD1 and small cell lung carcinoma: Studies have shown that the combination of ICIs, such as anti‐PD‐1, anti‐PD‐L1, and anti‐CTLA‐4, in combination with CT improves survival compared to CT alone in patients with ES‐SCLC [17, 18].